Our results support the idea that tumor-induced inhibition of DCdifferentiation is systemic and most likely caused by multiple factors.Clinical approaches to reverse this process should, therefore, encompasssystemic blockade of additional tumor-derived immunosuppressive cytokinesbesides VEGF. This evidence concerns the gene VEGFA and neoplasm.